JOHNSON & JOHNSON — Director's Dealing 2017

Feb 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2017-02-10

Reporting Person: Pruden Gary J (Exec VP, WW Chair, Med Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-10	Common Stock	M	6213.0000	—	Acquired	49843.4236	Direct
2017-02-10	Common Stock	F	1970.0000	$115.1300	Disposed	47873.4236	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-10	Restricted Share Units	$	M	6213.0000	Disposed		Common Stock (6213.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	96.0000	Indirect

Footnotes

F1: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date.

F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

F3: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2017).